GC
TMDX icon

Guggenheim Capital’s Transmedics TMDX Stock Holding History

Guggenheim Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509K Buy
7,665
+5,528
+259% +$468K ﹤0.01% 1284
2026
Q1 		$212K Sell
2,137
-10,405
-83% -$1.36M ﹤0.01% 1507
2025
Q4 		$1.53M Buy
12,542
+10,146
+423% +$1.27M 0.01% 761
2025
Q3 		$269K Buy
2,396
+112
+5% +$13.1K ﹤0.01% 1421
2025
Q2 		$306K Buy
+2,284
New +$251K ﹤0.01% 1392
2024
Q4 		– Sell
-2,048
Closed -$322K – 1914
2024
Q3 		$322K Buy
+2,048
New +$316K ﹤0.01% 1583

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Guggenheim Capital's TMDX Position: Q2 2026 in Review

Guggenheim Capital increased its Transmedics (TMDX) stake by 259% in Q2 2026, buying an estimated $468K and bringing the position to 7,665 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

Guggenheim Capital first reported a position in TMDX in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.53M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Guggenheim Capital held 7,665 shares of Transmedics worth $509K as of Q2 2026.
  • Guggenheim Capital bought 5,528 Transmedics shares in Q2 2026, an estimated $468K.
  • Transmedics made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1284 holding.
  • Guggenheim Capital first reported a position in Transmedics in Q3 2024 and has held it in 6 quarters since.
  • Guggenheim Capital's Transmedics position peaked at $1.53M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.